Valuation: IXICO plc

Market Cap 17.72M 23.66M 20.72M 19.09M 33.64M 2.26B 34.1M 228M 88.92M 1.11B 88.86M 86.91M 3.84B P/E 2026 *
-5.08x
P/E 2027 * -6.25x
Enterprise Value 8.12M 10.84M 9.49M 8.74M 15.41M 1.03B 15.62M 105M 40.73M 508M 40.71M 39.81M 1.76B EV / Sales 2026 *
1.08x
EV / Sales 2027 * 1.34x
Free-Float
89.25%
Yield 2026 *
-
Yield 2027 * -
1 day-1.52%
1 week-3.85%
Current month-2.11%
1 month-6.07%
3 months+3.17%
6 months-30.85%
Current year-30.85%
1 week 8
Extreme 8
8.5
1 month 8
Extreme 8
9
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
21
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 18/08/2024
Director of Finance/CFO 50 20/08/2019
Chief Tech/Sci/R&D Officer - 31/05/2025
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 20/08/2019
Director/Board Member 60 20/01/2022
Date Insider Type Main position Quantity % Market Cap.
12/06/25Free 350,000 0.3777%
12/06/25Sell

Chief Financial Officer

45,263 0.0488%
12/06/25Buy

Chief Financial Officer

45,263 0.0488%
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-3.85%-16.67%-57.24% 23.66M
+1.08%+7.56%+3.61%+9.84% 50.25B
+0.40%-1.37%+401.69%+625.15% 40.39B
-0.52%+6.57%+25.41%-5.37% 34.38B
+3.97%+6.71%+26.06%+63.36% 34.4B
-4.19%-1.84%+3.76%+32.17% 26.32B
-2.40%+1.60% - - 16.64B
+1.34%+5.68%+75.77%+141.51% 16.14B
-0.95%+0.76%+12.92%+21.59% 13.71B
+1.69%+3.09%+93.44%+99.19% 13.75B
Average -0.11%+2.82%+69.55%+103.36% 24.6B
Weighted average by Cap. +0.29%+4.03%+91.38%+141.82%

Financials

2026 *2027 *
Net sales 7.5M 10.02M 8.77M 8.08M 14.24M 955M 14.43M 96.72M 37.64M 469M 37.62M 36.79M 1.63B 9M 12.02M 10.53M 9.7M 17.09M 1.15B 17.32M 116M 45.17M 563M 45.14M 44.15M 1.95B
Net income -2.4M -3.21M -2.81M -2.59M -4.56M -306M -4.62M -30.95M -12.05M -150M -12.04M -11.77M -520M -2.8M -3.74M -3.28M -3.02M -5.32M -357M -5.39M -36.11M -14.05M -175M -14.04M -13.74M -607M
Net Debt -9.6M -12.82M -11.23M -10.34M -18.23M -1.22B -18.48M -124M -48.18M -600M -48.15M -47.09M -2.08B -5.7M -7.61M -6.67M -6.14M -10.82M -726M -10.97M -73.51M -28.61M -356M -28.59M -27.96M -1.24B
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
06/07/26 GBX 8.125 -1.52% 32,029
03/07/26 GBX 8.250 0.00% 32,224
02/07/26 GBX 8.250 0.00% 81,657
01/07/26 GBX 8.250 -0.60% 7,600
30/06/26 GBX 8.300 -1.78% 86,425
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0812GBP
Average target price
0.2600GBP
Spread / Average Target
+220.00%

Annual profits - Rate of surprise